359 related articles for article (PubMed ID: 23453634)
21. Syk is required for BCR-mediated activation of p90Rsk, but not p70S6k, via a mitogen-activated protein kinase-independent pathway in B cells.
Li HL; Forman MS; Kurosaki T; Puré E
J Biol Chem; 1997 Jul; 272(29):18200-8. PubMed ID: 9218456
[TBL] [Abstract][Full Text] [Related]
22. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
Whillock AL; Ybarra TK; Bishop GA
J Biol Chem; 2021; 296():100465. PubMed ID: 33639170
[TBL] [Abstract][Full Text] [Related]
23. Role of Syk in B-cell development and antigen-receptor signaling.
Cornall RJ; Cheng AM; Pawson T; Goodnow CC
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1713-8. PubMed ID: 10677523
[TBL] [Abstract][Full Text] [Related]
24. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
[TBL] [Abstract][Full Text] [Related]
25. BAFFR activates PI3K/AKT signaling in human naive but not in switched memory B cells through direct interactions with B cell antigen receptors.
Sevdali E; Block V; Lataretu M; Li H; Smulski CR; Briem JS; Heitz Y; Fischer B; Ramirez NJ; Grimbacher B; Jäck HM; Voll RE; Hölzer M; Schneider P; Eibel H
Cell Rep; 2022 Jun; 39(13):111019. PubMed ID: 35767961
[TBL] [Abstract][Full Text] [Related]
26. The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Igalpha cytoplasmic domain.
Patterson HC; Kraus M; Kim YM; Ploegh H; Rajewsky K
Immunity; 2006 Jul; 25(1):55-65. PubMed ID: 16860757
[TBL] [Abstract][Full Text] [Related]
27. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
28. Reconstitution of B cell antigen receptor-induced signaling events in a nonlymphoid cell line by expressing the Syk protein-tyrosine kinase.
Richards JD; Gold MR; Hourihane SL; DeFranco AL; Matsuuchi L
J Biol Chem; 1996 Mar; 271(11):6458-66. PubMed ID: 8626447
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
30. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
Piatelli MJ; Doughty C; Chiles TC
J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
[TBL] [Abstract][Full Text] [Related]
31. B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase.
Pogue SL; Kurosaki T; Bolen J; Herbst R
J Immunol; 2000 Aug; 165(3):1300-6. PubMed ID: 10903730
[TBL] [Abstract][Full Text] [Related]
32. Signalling crosstalk in B cells: managing worth and need.
Cancro MP
Nat Rev Immunol; 2009 Sep; 9(9):657-61. PubMed ID: 19704418
[TBL] [Abstract][Full Text] [Related]
33. Arginine methylation of the B cell antigen receptor promotes differentiation.
Infantino S; Benz B; Waldmann T; Jung M; Schneider R; Reth M
J Exp Med; 2010 Apr; 207(4):711-9. PubMed ID: 20231378
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.
Hsueh RC; Hammill AM; Lee JA; Uhr JW; Scheuermann RH
BMC Immunol; 2002 Dec; 3():16. PubMed ID: 12470302
[TBL] [Abstract][Full Text] [Related]
35. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
36. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
Chen L; Monti S; Juszczynski P; Daley J; Chen W; Witzig TE; Habermann TM; Kutok JL; Shipp MA
Blood; 2008 Feb; 111(4):2230-7. PubMed ID: 18006696
[TBL] [Abstract][Full Text] [Related]
37. B cell receptor (BCR) cross-talk: IL-4 creates an alternate pathway for BCR-induced ERK activation that is phosphatidylinositol 3-kinase independent.
Guo B; Rothstein TL
J Immunol; 2005 May; 174(9):5375-81. PubMed ID: 15843535
[TBL] [Abstract][Full Text] [Related]
38. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
39. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
[TBL] [Abstract][Full Text] [Related]
40. Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin.
Parameswaran N; Enyindah-Asonye G; Bagheri N; Shah NB; Gupta N
J Immunol; 2013 Mar; 190(5):2017-26. PubMed ID: 23338238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
